THE GLOBAL IMMUNOGLOBULINS MARKET SIZE WAS VALUED AT USD 13.59 BILLION IN 2020 AND IS EXPECTED TO REACH USD 21.58 BILLION BY 2026, GROWING AT A CAGR OF 8.01% DURING THE FORECAST PERIOD

Global Immunoglobulins Market Size, Share, Trends Analysis Report by Product (Intravenous Immunoglobulin, Subcutaneous Immunoglobulin, & Intramuscular Immunoglobulin) By Application (Primary Immunodeficiency, Chronic Immune Deficiency Polyradiculoneuropathy, Secondary Immunodeficiency, Immune Thrombocytopenic Purpura, Myasthenia Gravis, and Others), By End User (Hospital & Clinic, Homecare), By Geography (North America, Europe, APAC, Latin America, Middle East & Africa) Industry Analysis Report Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2021–2026

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

262 Pages

105 Tables

125 Charts

5 Regions

18 Countries

13 Companies

4 Market Segment

IMMUNOGLOBULINS MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 21.58 Billion USD (2026)
CAGR 8.01% (2021-2026)
BASE YEAR 2020
FORECAST YEAR 2021-2026
MARKET SEGMENTS By Product (Intravenous Immunoglobulin, Subcutaneous Immunoglobulin, & Intramuscular Immunoglobulin) By Application (Primary Immunodeficiency, Chronic Immune Deficiency Polyradiculoneuropathy, Secondary Immunodeficiency, Immune Thrombocytopenic Purpura, Myasthenia Gravis, and Others), By End User (Hospital & Clinic, Homecare)
GEOGRAPHIC ANALYSIS North America, Europe, APAC, Latin America, Middle East & Africa
COUNTRIES COVERED US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Turkey

MARKET OVERVIEW

The global immunoglobulins market was valued at USD 13.5 Billion in 2020 and is expected to reach USD 21.58 Billion by 2026, growing at a CAGR of 8.01% during the forecast period. The pandemic has had and continues to have a major impact on the plasma derivatives industry. It contributed to the increase in the cost/liter of collected plasma due to the increased donor fees and increased incidence of a fixed cost of centers with respect to the lower volumes collected. The recent developments and the increasing scope of immunoglobulin products in treating numerous rare and autoimmune diseases have increased the growth rate for the immunoglobulin industry.

KEY HIGHLIGHTS

  • The price of immunoglobulin increased by around 5% in Europe and by 6% in the US.
  • With the increasing outcome of the fractionation and the challenge of plasma shortage, the technological and scientific developments in the field of plasma fractionation are expected to drive the market of immunoglobins.
  • Immunoglobulins dominate the industry of plasma-derived products. This share is largely attributed to the increasing demand resulting from developed ways of diagnosing autoimmune diseases.
  • The major challenge for the immunoglobulin industry is to maintain the balance between supply and demand. As the immunoglobulin products require blood plasma, the production value is limited by the quantity of plasma collected.
  • Partnerships with the official plasma collection agencies of the country have propelled the growth of many vendors.

SEGMENTATION ANALYSIS

  • Intravenous immunoglobulins (IVIG) are the most used form of immunoglobulin to manage autoimmune diseases and immunodeficiency. Since the proposed therapeutic use of immunoglobulins, it is being administered through the intravenous route, which provides maximum bioavailability and maximum efficacy.
  • The market is led by primary immunodeficiency, which acquired 26.05% of the global immunoglobulins market in 2020. The symptoms of primary immunodeficiencies are frequent pneumonia, baronial infections, sinus infection, skin infections, meningitis, inflammation, low platelet count, etc.
  • The largest immunoglobulins market share based on end-users is acquired by the hospital and clinic segment. The home care segment is expected to grow faster because of the increasing demand for home healthcare services.

GEOGRAPHICAL ANALYSIS

  • North America acquired a 46.00% share of the global immunoglobulins market in 2020. This is attributed to many factors such as higher awareness towards personal health, a patient-centric healthcare system, advancements in healthcare, higher throughput of plasma collection centers, leading global vendors being native to the industry, etc.
  • Europe is the second-largest market for immunoglobulin products because of its higher demand compared to other regions. The region has a higher awareness and highly regulated market, which enables safe blood and plasma collection practices.
  • APAC is considered an emerging industry for immunoglobulin products, which are needed for treating autoimmune disorders. China is leading the APAC immunoglobulins market. The Chinese population has a higher awareness of blood donation and its possible use in manufacturing life-saving products.

VENDOR ANALYSIS

  • The key players in the immunoglobulins industry are Takeda Pharmaceutical, CSL Limited, Grifols, S.A, Kendrion Biopharma, and Octapharma AG.
  • The global immunoglobulins industry is dominated by mainly three vendors, CSL Limited, Takeda Pharmaceutical Company Limited, and Grifols S.A. They share a highly competitive environment, where each competes in terms of newer product launches and regulatory approval for those and existing products.
  • For new vendors, emerging markets and low-resource countries are ideal markets, as they have a higher population and greater inclination towards donating blood or plasma in compensation.
  • For the vendors in the immunoglobulins industry, it is crucial to procure the plasma for fractionation. It can be done through wide installations of plasma collection centers across the countries, allowing the collection of higher volumes of plasma.
  • Partnerships with the official plasma collection agencies of the country have propelled the growth of many vendors. Many new vendors have been benefitted from such partnerships.


The global immunoglobulins market research report includes an in-depth analysis of the industry analysis with market dynamics, competitive landscape, drivers, and restraints for the following segments

By Product

  • Intravenous Immunoglobulin
  • Subcutaneous Immunoglobulin
  • Intramuscular Immunoglobulin

By Application

  • Primary Immunodeficiency
  • Chronic Immune Deficiency Polyradiculoneuropathy
  • Secondary Immunodeficiency
  • Immune Thrombocytopenic Purpura
  • Myasthenia Gravis
  • Others

By End User

  • Hospital & Clinic
  • Homecare

By Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey

Frequently Asked Questions

The global immunoglobulins market was valued at USD 13.59 billion in 2020 and is expected to reach USD 21.58 billion by 2026.
The key trends are developments in the plasma Fractionation Process, immunoglobulins in homecare, and recent regulatory approvals for immunoglobulin.
North America region accounted for the largest Immunoglobulins Market share.
The key players are Takeda Pharmaceutical, CSL Limited, Grifols, S.A, Kendrion Biopharma, and Octapharma AG
The factors driving the immunoglobulins market are the impact of the use of IVIg during transplant and self-sufficiency programs for plasma-derived medicinal products.
Download Free Sample

The global immunoglobulins market was valued at USD 13.59 billion in 2020 and is expected to reach USD 21.58 billion by 2026, growing at a CAGR of 8.01% during the forecast period.

The following factors are likely to contribute to the growth of the immunoglobulins market during the forecast period:

  • impact of the use of IVIg during transplant
  • self-sufficiency programs for plasma-derived medicinal products
  • Fractionation Process, and immunoglobulins in homecare
  • Recent regulatory approvals for immunoglobulin.

Base Year:  2020

Forecast Year:  2021–2026

The study considers the immunoglobulins market present scenario and it's market dynamics for the period 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Major Vendors

  • Takeda Pharmaceutical Company Limited
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • CSL Limited
  • Grifols, S.A
  • Kendrion Biopharma
  • Octapharma AG.

Other Prominent Vendors

  • China Biologic Products Holding, Inc.
    • Business Overview
    • Product Offerings
  • Biotest AG
  • LFB S.A.
  • ADMA Biologics, Inc.
  • Omrix Biopharmaceuticals LTD
  • Zydus Cadila
  • Bharat Serums And Vaccines Limited
  • Reliance Life Sciences

Segmentation By Product

  • Intravenous Immunoglobulin
  • Subcutaneous Immunoglobulin
  • Intramuscular Immunoglobulin

Segmentation By Application

  • Primary Immunodeficiency
  • Chronic Immune Deficiency Polyradiculoneuropathy
  • Secondary Immunodeficiency
  • Immune Thrombocytopenic Purpura
  • Myasthenia Gravis
  • Others

By End User

  • Hospital & Clinic
  • Homecare

By Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey

1            Research Methodology

2            Research Objectives

3            Research Process

 

4            Scope & Coverage

4.1         Market Definition

4.1.1      Inclusions

4.1.2      Exclusions

4.1.3      Market Estimation Caveats

4.2         Base Year

4.3         Scope of the Study

4.3.1      Market Segmentation by Product Type

4.3.2      Market Segmentation by Application

4.3.3      Market Segmentation by End-user

4.3.4      Market Segmentation by Geography

 

5            Report Assumptions & Caveats

5.1         Key Caveats

5.2         Currency Conversion

5.3         Market Derivation

 

6            Market at a Glance

 

7            Introduction

7.1         Overview

7.2         COVID-19 Impact on Plasma Therapies

 

8            Market Opportunities & Trends

8.1         Developments in Plasma Fractionation Process

8.2         Immunoglobulins in Homecare

 

9            Market Growth Enablers

9.1         Recent Regulatory Approvals for Immunoglobulins

9.2         Use of IVIG During Transplant

9.3         Self-Sufficiency Programs for Plasma-Derived Medicinal Products

 

10         Market Growth Restraints

10.1       IVIG-Associated Hemolysis

10.2       Shortage of Immunoglobulin Products

 

11         Market Landscape

11.1      Market Overview

11.2      Market Size & Forecast

11.2.1   Product Type Insights

11.2.2   Application Insights

11.2.3   End-user Insights

11.2.4   Geographic Insights

11.3      Five Forces Analysis

11.3.1   Threat of New Entrants

11.3.2   Bargaining Power of Suppliers

11.3.3   Bargaining Power of Buyers

11.3.4   Threat of Substitutes

11.3.5   Competitive Rivalry

 

12         Product

12.1      Market Snapshot & Growth Engine

12.2      Market Overview

12.3      Intravenous Immunoglobulins

12.3.1   Market Overview

12.3.2   Market Size & Forecast

12.3.3   Intravenous Immunoglobulins: Geographical Segmentation

12.4      Subcutaneous Immunoglobulins

12.4.1   Market Overview

12.4.2   Market Size & Forecast

12.4.3   Subcutaneous Immunoglobulins: Geographical Segmentation

12.5      Intramuscular Immunoglobulins

12.5.1   Market Overview

12.5.2   Market Size & Forecast

12.5.3   Intramuscular Immunoglobulins: Geographical Segmentation

 

13         Application

13.1      Market Snapshot & Growth Engine

13.2      Market Overview

13.3      Primary Immunodeficiency

13.3.1   Market Overview

13.3.2   Market Size & Forecast

13.3.3   Primary Immunodeficiency: Geography Segmentation

13.4      Chronic Immune Deficiency Polyradiculoneuropathy

13.4.1   Market Overview

13.4.2   Market Size & Forecast

13.4.3   Chronic Immune Deficiency Polyradiculoneuropathy: Geography Segmentation

13.5      Secondary Immunodeficiency

13.5.1   Market Overview

13.5.2   Market Size & Forecast

13.5.3   Secondary Immunodeficiency: Geography Segmentation

13.6      Immune Thrombocytopenic Purpura

13.6.1   Market Overview

13.6.2   Market Size & Forecast

13.6.3   Immune Thrombocytopenic Purpura: Geography Segmentation

13.7      Myasthenia Gravis

13.7.1   Market Overview

13.7.2   Market Size & Forecast

13.7.3   Myasthenia Gravis: Geography Segmentation

13.8      Others

13.8.1   Market Overview

13.8.2   Market Size & Forecast

13.8.3   Others: Geographical Segmentation

 

14         End-User

14.1      Market Snapshot & Growth Engine

14.2      Market Overview

14.3      Hospitals & Clinics

14.3.1   Market Overview

14.3.2   Market Size & Forecast

14.3.3   Hospitals & Clinics: Geography Segmentation

14.4      Homecare

14.4.1   Market Overview

14.4.2   Market Size & Forecast

14.4.3   Homecare: Geography Segmentation

 

15         Geography

15.1      Market Snapshot & Growth Engine

15.2      Geographic Overview

 

16         North America

16.1      Market Overview

16.2      Market Size & Forecast

16.2.1   North America: Product Type Segmentation

16.2.2   North America: Application Segmentation

16.2.3   North America: End-user Segmentation

16.3      Key Countries

16.3.1   US: Market Size & Forecast

16.3.2   Canada: Market Size & Forecast

 

17         Europe

17.1      Market Overview

17.2      Market Size & Forecast

17.2.1   Europe: Product Type Segmentation

17.2.2   Europe: Application Segmentation

17.2.3   Europe: End-user Segmentation

17.3      Key Countries

17.3.1   Germany: Market Size & Forecast

17.3.2   France: Market Size & Forecast

17.3.3   UK: Market Size & Forecast

17.3.4   Italy: Market Size & Forecast

17.3.5   Spain: Market Size & Forecast

 

18         APAC

18.1      Market Overview

18.2      Market Size & Forecast

18.2.1   APAC: Product Type Segmentation

18.2.2   APAC: Application Segmentation

18.2.3   APAC: End-user Segmentation

18.3      Key Countries

18.3.1   China: Market Size & Forecast

18.3.2   Japan: Market Size & Forecast

18.3.3   India: Market Size & Forecast

18.3.4   Australia: Market Size & Forecast

18.3.5   South Korea: Market Size & Forecast

 

19         Latin America

19.1      Market Overview

19.2      Market Size & Forecast

19.2.1   Latin America: Product Type Segmentation

19.2.2   Latin America: Application Segmentation

19.2.3   Latin America: End-user Segmentation

19.3      Key Countries

19.3.1   Brazil: Market Size & Forecast

19.3.2   Mexico: Market Size & Forecast

19.3.3   Argentina: Market Size & Forecast

 

20         Middle East & Africa

20.1      Market Overview

20.2      Market Size & Forecast

20.2.1   Middle East & Africa: Product Type Segmentation

20.2.2   Middle East & Africa: Application Segmentation

20.2.3   Middle East & Africa: End-user Segmentation

20.3      Key Countries

20.3.1   South Africa: Market Size & Forecast

20.3.2   Saudi Arabia: Market Size & Forecast

20.3.3   Turkey: Market Size & Forecast

 

21         Competitive Landscape

21.1      Competition Overview

21.2      Market Share Analysis

21.2.1   CSL Limited

21.2.2   Takeda Pharmaceutical Company Limited

21.2.3   Grifols S.A.

 

22         Key Company Profiles

22.1      Takeda Pharmaceutical Company Limited

22.1.1   Business Overview

22.1.2   Takeda Pharmaceutical Company Limited in Immunoglobulins Market

22.1.3   Product Offerings

22.1.4   Key Strategies

22.1.5   Key Strengths

22.1.6   Key Opportunities

22.2      CSL Limited

22.2.1   Business Overview

22.2.2   CSL in Immunoglobulins Market

22.2.3   Product Offerings

22.2.4   Key Strategies

22.2.5   Key Strengths

22.2.6   Key Opportunities

22.3      Grifols, S.A.

22.3.1   Business Overview

22.3.2   Grifols, S.A. in Immunoglobulins Market

22.3.3   Product Offerings

22.3.4   Key Strategies

22.3.5   Key Strengths

22.3.6   Key Opportunities

22.4      Kendrion Biopharma

22.4.1   Business Overview

22.4.2   Kendrion in Immunoglobulins Market

22.4.3   Product Offerings

22.4.4   Key Strategies

22.4.5   Key Strengths

22.4.6   Key Opportunities

22.5      Octapharma AG

22.5.1   Business Overview

22.5.2   Octapharma AG in Immunoglobulins Market

22.5.3   Product Offerings

22.5.4   Key Strategies

22.5.5   Key Strengths

22.5.6   Key Opportunities

 

23         Other Prominent Vendors

23.1      China Biologic Products Holdings, Inc.

23.1.1   Business Overview

23.1.2   Product Offerings

23.2      Biotest AG

23.2.1   Business Overview

23.2.2   Product Offerings

23.3      LFB S.A.

23.3.1   Business Overview

23.3.2   Product Offerings

23.4      Adma Biologics, Inc.

23.4.1   Business Overview

23.4.2   Product Offerings

23.5      Omrix Biopharmaceuticals Ltd

23.5.1   Business Overview

23.5.2   Product Offerings

23.6      Zydus Cadila

23.6.1   Business Overview

23.6.2   Product Offerings

23.7      Bharat Serums and Vaccines Limited

23.7.1   Business Overview

23.7.2   Product Offerings

23.8      Reliance Life Sciences

23.8.1   Business Overview

23.8.2   Product Offerings

 

24         Report Summary

24.1      Key Takeaways

24.2      Strategic Recommendations

 

25         Quantitative Summary

25.1       Market by Product Type

25.1.1    North America: Product Type Segmentation

25.1.2    Europe: Product Type Segmentation

25.1.3    APAC: Product Type Segmentation

25.1.4    Latin America: Product Type Segmentation

25.1.5    Middle East & Africa: Product Type Segmentation

25.2       Market by Application

25.2.1    North America: Application Segmentation

25.2.2    Europe: Application Segmentation

25.2.3    APAC: Application Segmentation

25.2.4    Latin America: Application Segmentation

25.2.5    Middle East & Africa: Application Segmentation

25.3       Market by End-User

25.3.1    North America: End-user Segmentation

25.3.2    Europe: Market Size & Forecast

25.3.3    APAC: Market Size & Forecast

25.3.4    Latin America: Market Size & Forecast

25.3.5    Middle East & Africa: Market Size & Forecast

25.4       Market by Geography

25.4.1    Intravenous Immunoglobulin: Geography Segmentation

25.4.2    Subcutaneous Immunoglobulins: Geography Segmentation

25.4.3    Intramuscular Immunoglobulins: Geography Segmentation

25.4.4    Primary Immunodeficiency: Geography Segmentation

25.4.5    Chronic Immune Deficiency Polyradiculoneuropathy: Geography Segmentation

25.4.6    Secondary Immunodeficiency: Geography Segmentation

25.4.7    Immune Thrombocytopenic Purpura: Geography Segmentation

25.4.8    Myasthenia Gravis: Geography Segmentation

25.4.9    Others: Geography Segmentation

25.4.10  Hospitals & Clinics: Geography Segmentation

25.4.11  Homecare: Geography Segmentation

 

26         Appendix

26.1      Abbreviations

Exhibit 1             Segmentation of Global Immunoglobulins Market

Exhibit 2             Market Size Calculation Approach 2020

Exhibit 3             Impact of Developments in Plasma Fractionation Process

Exhibit 4             Impact of Immunoglobulins in Homecare

Exhibit 5             Impact of Recent Regulatory Approvals for Immunoglobulin

Exhibit 6             Impact of Use of IVIg During Transplant

Exhibit 7             Self-sufficiency Programs for Plasma-derived Medicinal Products

Exhibit 8             Impact of IVIg-associated Hemolysis

Exhibit 9             Impact of Shortage of Immunoglobulin Products

Exhibit 10           Global Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 11           Global Immunoglobulins Market by Product Type

Exhibit 12           Global Immunoglobulins Market by Application

Exhibit 13           Global Immunoglobulins Market by End-user

Exhibit 14           Global Immunoglobulins Market by Geography

Exhibit 15           Five Forces Analysis 2020

Exhibit 16           Incremental Growth by Product Type 2020 & 2026

Exhibit 17           Global Immunoglobulins Market by Product Type

Exhibit 18           Global Immunoglobulins Market by Product Type: Incremental Growth 2020–2026 ($ billion)

Exhibit 19           Global Immunoglobulins Market by Product Type: Absolute Growth 2020–2026 (%)

Exhibit 20           Global Intravenous Immunoglobulins Market: Incremental & Absolute Growth

Exhibit 21           Global Intravenous Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 22           Incremental Growth by Geography 2020 & 2026

Exhibit 23           Global Subcutaneous Immunoglobulins Market: Incremental & Absolute Growth

Exhibit 24           Global Subcutaneous Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 25           Incremental Growth by Geography 2020 & 2026

Exhibit 26           Global Intramuscular Immunoglobulins Market: Incremental & Absolute Growth

Exhibit 27           Global Intramuscular Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 28           Incremental Growth by Geography 2020 & 2026

Exhibit 29           Incremental Growth by Segment 2020 & 2026

Exhibit 30           Global Immunoglobulins Market by Application

Exhibit 31           Global Immunoglobulins Market by Application: Incremental Growth 2020–2026 ($ billion)

Exhibit 32           Global Immunoglobulins Market by Application: Absolute Growth 2020–2026 ($ billion)

Exhibit 33           Global Primary Immunodeficiency Market: Incremental & Absolute Growth

Exhibit 34           Global Primary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 35           Incremental Growth by Geography 2020 & 2026

Exhibit 36           Global CIDP Immunoglobulins Market: Incremental & Absolute Growth

Exhibit 37           Global CIDP Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 38           Incremental Growth by Geography 2020 & 2026

Exhibit 39           Global Secondary Immunodeficiency Immunoglobulins Market: Incremental & Absolute Growth

Exhibit 40           Global Secondary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 41           Incremental Growth by Geography 2020 & 2026

Exhibit 42           Global Immune Thrombocytopenic Purpura Immunoglobulins Market: Incremental & Absolute Growth

Exhibit 43           Global Immune Thrombocytopenic Purpura Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 44           Incremental Growth by Geography 2020 & 2026

Exhibit 45           Global Myasthenia Gravis Immunoglobulins Market: Incremental Growth & Absolute Growth

Exhibit 46           Global Myasthenia Gravis Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 47           Incremental Growth by Geography 2020 & 2026

Exhibit 48           Global Immunoglobulins Market by Others: Incremental & Absolute Growth

Exhibit 49           Global Other Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 50           Incremental Growth by Geography 2020 & 2026

Exhibit 51           Incremental Growth by Application 2020 & 2026

Exhibit 52           Global Immunoglobulins Market by End-user

Exhibit 53           Global Immunoglobulins Market by End-user: Incremental Growth 2020–2026 ($ billion)

Exhibit 54           Global Immunoglobulins Market by End-user: Absolute Growth 2020–2026 (%)

Exhibit 55           Global Hospitals & Clinics Immunoglobulins Market: Incremental & Absolute Growth

Exhibit 56           Global Hospitals & Clinics Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 57           Incremental Growth by Geography 2020 & 2026

Exhibit 58           Global Homecare Immunoglobulins Market: Incremental & Absolute Growth

Exhibit 59           Global Homecare Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 60           Incremental Growth by Geography 2020 & 2026

Exhibit 61           Incremental Growth by Geography 2020 & 2026

Exhibit 62           Global Immunoglobulins Market: Key Countries

Exhibit 63           Global Immunoglobulins Market by Geography: Incremental Growth 2020–2026 ($ billion)

Exhibit 64           Global Immunoglobulins Market by Geography: Absolute Growth 2020–2026 (%)

Exhibit 65           North America Immunoglobulins Market: Key Countries 2020 ($ billion)

Exhibit 66           North America Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 67           Incremental Growth by Product Type 2020 & 2026

Exhibit 68           Incremental Growth by Application 2020 & 2026

Exhibit 69           Incremental Growth by End-user 2020 & 2026

Exhibit 70           Incremental Growth in North America 2020 & 2026

Exhibit 71           Immunoglobulins Market in US 2020–2026 ($ billion)

Exhibit 72           Immunoglobulins Market in Canada 2020–2026 ($ billion)

Exhibit 73           Europe Immunoglobulins Market: Key Countries 2020 ($ billion)

Exhibit 74           Europe Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 75           Incremental Growth by Product Type 2020 & 2026

Exhibit 76           Incremental Growth by Application 2020 & 2026

Exhibit 77           Incremental Growth by End-user 2020 & 2026

Exhibit 78           Incremental Growth in Europe 2020 & 2026

Exhibit 79           Immunoglobulins Market in Germany 2020–2026 ($ billion)

Exhibit 80           Immunoglobulins Market in France 2020–2026 ($ billion)

Exhibit 81           Immunoglobulins Market in UK 2020–2026 ($ billion)

Exhibit 82           Immunoglobulins Market in Italy 2020–2026 ($ billion)

Exhibit 83           Immunoglobulins Market in Spain 2020–2026 ($ billion)

Exhibit 84           APAC Immunoglobulins Market: Key Countries 2020 ($ billion)

Exhibit 85           Immunoglobulins Market in APAC 2020–2026 ($ billion)

Exhibit 86           Incremental Growth by Product Type 2020 & 2026

Exhibit 87           Incremental Growth by Application 2020 & 2026

Exhibit 88           Incremental Growth by End-user 2020 & 2026

Exhibit 89           Incremental Growth in APAC 2020 & 2026

Exhibit 90           Immunoglobulins Market in China 2020–2026 ($ billion)

Exhibit 91           Immunoglobulins Market in Japan 2020–2026 ($ billion)

Exhibit 92           Immunoglobulins Market in India 2020–2026 ($ billion)

Exhibit 93           Immunoglobulins Market in Australia 2020–2026 ($ billion)

Exhibit 94           Immunoglobulins Market in South Korea 2020–2026 ($ billion)

Exhibit 95           Latin America Immunoglobulins Market: Key Countries 2020 ($ billion)

Exhibit 96           Latin America Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 97           Incremental Growth by Product Type 2020 & 2026

Exhibit 98           Incremental Growth by Application 2020 & 2026

Exhibit 99           Incremental Growth by End-user 2020 & 2026

Exhibit 100        Incremental Growth in Latin America 2020 & 2026

Exhibit 101        Immunoglobulins Market in Brazil 2020–2026 ($ billion)

Exhibit 102        Immunoglobulins Market in Mexico 2020–2026 ($ billion)

Exhibit 103        Immunoglobulins Market in Argentina 2020–2026 ($ billion)

Exhibit 104        Middle East & Africa Immunoglobulins Market: Key Countries 2020 ($ billion)

Exhibit 105        Middle East & Africa Immunoglobulins Market 2020–2026 ($ billion)

Exhibit 106        Incremental Growth by Product Type 2020 & 2026

Exhibit 107        Incremental Growth by Application 2020 & 2026

Exhibit 108        Incremental Growth by End-user 2020 & 2026

Exhibit 109        Incremental Growth in Middle East & Africa 2020 & 2026

Exhibit 110        Immunoglobulins Market in South Africa 2020–2026 ($ billion)

Exhibit 111        Immunoglobulins Market in Saudi Arabia 2020–2026 ($ billion)

Exhibit 112        Immunoglobulins Market in Turkey 2020–2026 ($ billion)

Exhibit 113        Global Immunoglobulins Market: Vendor Market Share (2020)

Exhibit 114        Takeda Pharmaceutical Company Limited: Total Revenue 2018−2020 ($ billion)

Exhibit 115        Takeda Pharmaceutical Company Limited: Total Revenue by Geography 2019 & 2020 ($ billion)

Exhibit 116        Takeda Pharmaceutical Company Limited: R&D Expenditure 2018−2020 ($ billion)

Exhibit 117        Takeda Pharmaceutical Company Limited: Total Revenue by Immunoglobin 2018−2020 ($ billion)

Exhibit 118        CSL Limited: Total Revenue 2018−2020 ($ million)

Exhibit 119        CSL Limited: R&D Expenditure 2018−2020 ($ million)

Exhibit 120        Grifols, S.A.: Total Revenue 2018−2020 ($ million)

Exhibit 121        Grifols, S.A.: R&D Expenditure 2018−2020 ($ million)

Exhibit 122        Kendrion: Total Revenue 2018−2020 ($ million)

Exhibit 123        Kendrion: R&D Expenditure 2018−2020 ($ million)

Exhibit 124        Octapharma AG: Total Revenue 2018−2020 ($ million)

Exhibit 125        Octapharma AG: R&D Expenditure 2018−2020 ($ million)            

LIST OF TABLES       

Table 1               Key Caveats

Table 2               Currency Conversion 2013−2020

Table 3               North America Immunoglobulins Market by Product Type 2020–2026 ($ billion)

Table 4               North America Immunoglobulins Market by Product Type 2020–2026 (%)

Table 5               North America Immunoglobulins Market by Application 2020–2026 ($ billion)

Table 6               North America Immunoglobulins Market by Application 2020–2026 (%)

Table 7               North America Immunoglobulins Market by End-user 2020–2026 ($ billion)

Table 8               North America Immunoglobulins Market by End-user 2020–2026 (%)

Table 9               Europe Immunoglobulins Market by Product Type 2020–2026 ($ billion)

Table 10             Europe Immunoglobulins Market by Product Type 2020–2026 (%)

Table 11             Europe Immunoglobulins Market by Application 2020–2026 ($ billion)

Table 12             Europe Immunoglobulins Market by Application 2020–2026 (%)

Table 13             Europe Immunoglobulins Market by End-user 2020–2026 ($ billion)

Table 14             Europe Immunoglobulins Market by End-user 2020–2026 (%)

Table 15             APAC Immunoglobulins Market by Product Type 2020–2026 ($ billion)

Table 16             APAC Immunoglobulins Market by Product Type 2020–2026 (%)

Table 17             APAC Immunoglobulins Market by Application 2020–2026 ($ billion)

Table 18             APAC Immunoglobulins Market by Application 2020–2026 (%)

Table 19             APAC Immunoglobulins Market by End-user 2020–2026 ($ billion)

Table 20             APAC Immunoglobulins Market by End-user 2020–2026 (%)

Table 21             Latin America Immunoglobulins Market by Product Type 2020–2026 ($ billion)

Table 22             Latin America Immunoglobulins Market by Product Type 2020–2026 (%)

Table 23             Latin America Immunoglobulins Market by Application 2020–2026 ($ billion)

Table 24             Latin America Immunoglobulins Market by Application 2020–2026 (%)

Table 25             Latin America Immunoglobulins Market by End-user 2020–2026 ($ billion)

Table 26             Latin America Immunoglobulins Market by End-user 2020–2026 (%)

Table 27             Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 ($ billion)

Table 28             Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 (%)

Table 29             Middle East & Africa Immunoglobulins Market by Application 2020–2026 ($ billion)

Table 30             Middle East & Africa Immunoglobulins Market by Application 2020–2026 (%)

Table 31             Middle East & Africa Immunoglobulins Market by End-user 2020–2026 ($ billion)

Table 32             Middle East & Africa Immunoglobulins Market by End-user 2020–2026 (%)

Table 33             Takeda Pharmaceutical Company Limited: Major Product Offerings

Table 34             CSL: Major Product Offerings

Table 35             Grifols, S.A.: Major Product Offerings

Table 36             Kendrion: Major Product Offerings

Table 37             Octapharma: Major Product Offerings

Table 38             China Biologic Products Holdings, Inc.: Major Product Offerings

Table 39             Biotest AG: Major Product Offerings

Table 40             LFB S.A.: Major Product Offerings

Table 41             ADMA Biologics, Inc.: Major Product Offerings

Table 42             Omrix Biopharmaceuticals LTD: Major Product Offerings

Table 43             Zydus Cadila: Major Product Offerings

Table 44             Bharat Serums and Vaccines Limited: Major Product Offerings

Table 45             Reliance Life Sciences: Major Product Offerings

Table 46             Global Immunoglobulins Market by Product Type 2020–2026 ($ billion)

Table 47             Global Immunoglobulins Market by Product Type 2020–2026 (%)

Table 48             North America Immunoglobulins Market by Product Type 2020–2026 ($ billion)

Table 49             North America Immunoglobulins Market by Product Type 2020–2026 (%)

Table 50             Europe Immunoglobulins Market by Product Type 2020–2026 ($ billion)

Table 51             Europe Immunoglobulins Market by Product Type 2020–2026 (%)

Table 52             APAC Immunoglobulins Market by Product Type 2020–2026 ($ billion)

Table 53             APAC Immunoglobulins Market by Product Type 2020–2026 (%)

Table 54             Latin America Immunoglobulins Market by Product Type 2020–2026 ($ billion)

Table 55             Latin America Immunoglobulins Market by Product Type 2020–2026 (%)

Table 56             Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 ($ billion)

Table 57             Middle East & Africa Immunoglobulins Market by Product Type 2020–2026 (%)

Table 58             Global Immunoglobulins Market by Application 2020–2026 ($ billion)

Table 59             Global Immunoglobulins Market by Application 2020–2026 (%)

Table 60             North America Immunoglobulins Market by Application 2020–2026 ($ billion)

Table 61             North America Immunoglobulins Market by Application 2020–2026 (%)

Table 62             Europe Immunoglobulins Market by Application 2020–2026 ($ billion)

Table 63             Europe Immunoglobulins Market by Application 2020–2026 (%)

Table 64             APAC Immunoglobulins Market by Application 2020–2026 ($ billion)

Table 65             APAC Immunoglobulins Market by Application 2020–2026 (%)

Table 66             Latin America Immunoglobulins Market by Application 2020–2026 ($ billion)

Table 67             Latin America Immunoglobulins Market by Application 2020–2026 (%)

Table 68             Middle East & Africa Immunoglobulins Market by Application 2020−2026 ($ billion)

Table 69             Middle East & Africa Immunoglobulins Market by Application 2020−2026 (%)

Table 70             Global Immunoglobulins Market by End-user 2020–2026 ($ billion)

Table 71             Global Immunoglobulins Market by End-user 2020–2026 (%)

Table 72             North America Immunoglobulins Market by End-user 2020–2026 ($ billion)

Table 73             North America Immunoglobulins Market by End-user 2020−2026 (%)

Table 74             Europe Immunoglobulins Market by End-user 2020–2026 ($ billion)

Table 75             Europe Immunoglobulins Market by End-user 2020–2026 (%)

Table 76             APAC Immunoglobulins Market by End-user 2020–2026 ($ billion)

Table 77             APAC Immunoglobulins Market by End-user 2020–2026 (%)

Table 78             Latin America Immunoglobulins Market by End-user 2020–2026 ($ billion)

Table 79             Latin America Immunoglobulins Market by End-user 2020–2026 (%)

Table 80             Middle East & Africa Immunoglobulins Market by End-user 2020–2026 ($ billion)

Table 81             Middle East & Africa Immunoglobulins Market by End-User 2020–2026 (%)

Table 82             Global Immunoglobulins Market by Geography 2020–2026 ($ billion)

Table 83             Global Immunoglobulins Market by Geography 2020–2026 (%)

Table 84             Global Intravenous Immunoglobulins Market 2020–2026 ($ billion)

Table 85             Global Intravenous Immunoglobulins Market 2020–2026 (%)

Table 86             Global Subcutaneous Immunoglobulins Market 2020–2026 ($ billion)

Table 87             Global Subcutaneous Immunoglobulins Market 2020–2026 (%)

Table 88             Global Intramuscular Immunoglobulins Market 2020–2026 ($ billion)

Table 89             Global Intramuscular Immunoglobulins Market 2020–2026 (%)

Table 90             Global Primary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)

Table 91             Global Primary Immunodeficiency Immunoglobulins Market 2020–2026 (%)

Table 92             Global CIDP Immunoglobulins Market 2020–2026 ($ billion)

Table 93             Global CIDP Immunoglobulins Market 2020–2026 (%)

Table 94             Global Secondary Immunodeficiency Immunoglobulins Market 2020–2026 ($ billion)

Table 95             Global Secondary Immunodeficiency Immunoglobulins Market 2020–2026 (%)

Table 96             Global Immune Thrombocytopenic Purpura Immunoglobulins Market 2020–2026 ($ billion)

Table 97             Global Immune Thrombocytopenic Purpura Immunoglobulins Market 2020–2026 (%)

Table 98             Global Myasthenia Gravis Immunoglobulins Market 2020–2026 ($ billion)

Table 99             Global Myasthenia Gravis Immunoglobulins Market 2020–2026 (%)

Table 100           Global Immunoglobulins Market by Others 2020–2026 ($ billion)

Table 101           Global Immunoglobulins Market by Others 2020–2026 (%)

Table 102           Global Hospitals & Clinics Immunoglobulins Market 2020–2026 ($ billion)

Table 103           Global Hospitals & Clinics Immunoglobulins Market 2020–2026 (%)

Table 104           Global Homecare Immunoglobulins Market 2020–2026 ($ billion)

Table 105           Global Homecare Immunoglobulins Market 2020–2026 (%)

Select a license type that suits your business needs

Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

YOU CAN GET A FREE SAMPLE OF THIS REPORT!

Fill out your details & get your free sample

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Our Clients

Licence Types What are these?

Our Clients Speak

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date